Preferred Name |
Zaleplon |
|
Synonyms |
|
|
Definitions |
A nonbenzodiazepine from the pyrazolopyrimidine class with hypnotic, sedative, anxiolytic, and muscle relaxant properties. Zaleplon interacts with the gamma-aminobutyric acid (GABA) -A receptor, thereby affecting the chloride channel ionophore complex and potentiating the inhibitory effects of GABA. In addition, zaleplon binds selectively to the brain omega-1 receptor situated on the alpha subunit of the GABA-A/chloride ion channel receptor complex and potentiates t-butyl-bicyclophosphorothionate (TBPS) binding. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C29551 |
|
CAS_Registry |
151319-34-5 |
|
CHEBI_ID |
CHEBI:10102 |
|
Chemical_Formula |
C17H15N5O |
|
code |
C29551 |
|
Contributing_Source |
FDA |
|
definition |
A nonbenzodiazepine from the pyrazolopyrimidine class with hypnotic, sedative, anxiolytic, and muscle relaxant properties. Zaleplon interacts with the gamma-aminobutyric acid (GABA) -A receptor, thereby affecting the chloride channel ionophore complex and potentiating the inhibitory effects of GABA. In addition, zaleplon binds selectively to the brain omega-1 receptor situated on the alpha subunit of the GABA-A/chloride ion channel receptor complex and potentiates t-butyl-bicyclophosphorothionate (TBPS) binding. |
|
FDA_UNII_Code |
S62U433RMH |
|
in_subset | ||
label |
Zaleplon |
|
Legacy Concept Name |
Zaleplon |
|
Preferred_Name |
Zaleplon |
|
prefixIRI |
NCIT:C29551 |
|
prefLabel |
Zaleplon |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C0251504 |
|
subClassOf |